Cough Reduction in IPF With Nalbuphine ER

Condition:   Idiopathic Pulmonary Fibrosis Interventions:   Drug: nalbuphine ER;   Drug: Placebo Sponsor:   Trevi Therapeutics Not yet recruiting

Source: ClinicalTrials.gov - July 27, 2023 Category: Research Source Type: clinical trials